The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
May. 25, 2023
Applicant:
L.e.a.f. Holdings Group Llc, Gulph Mills, PA (US);
Inventors:
Clet Niyikiza, Gulph Mills, PA (US);
Victor Mandla Moyo, Ringoes, NJ (US);
Assignee:
L.E.A.F. HOLDINGS GROUP LLC, Gulph Mills, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 47/26 (2006.01); A61K 47/54 (2017.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); A61K 47/69 (2017.01); A61K 49/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/1271 (2013.01); A61K 47/26 (2013.01); A61K 47/542 (2017.08); A61K 47/64 (2017.08); A61K 47/6849 (2017.08); A61K 47/6913 (2017.08); A61K 49/0084 (2013.01); A61P 35/00 (2018.01);
Abstract
The disclosure relates generally to alpha polyglutamated pralatrexate, formulations containing liposomes filled with alpha polyglutamated pralatrexate, methods of making the alpha polyglutamated pralatrexate and liposome containing formulations, and methods of using polyglutamated alpha polyglutamated pralatrexate and liposome containing formulations to treat hyperproliferative disorders (e.g., cancer) and disorders of the immune system (e.g., an autoimmune disease such as rheumatoid arthritis).